• LAST PRICE
    9.7200
  • TODAY'S CHANGE (%)
    Trending Down-0.2000 (-2.0161%)
  • Bid / Lots
    9.5700/ 4
  • Ask / Lots
    9.7500/ 1
  • Open / Previous Close
    9.9200 / 9.9200
  • Day Range
    Low 9.5700
    High 10.0710
  • 52 Week Range
    Low 7.0801
    High 40.9100
  • Volume
    1,093,516
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 9.92
TimeVolumeCVM
09:32 ET60909.85
09:37 ET11039.72
09:39 ET153089.9
09:42 ET2009.93
09:44 ET502009.81
09:46 ET517209.94
09:48 ET6479.95
09:50 ET2009.935
09:51 ET1239.8905
09:53 ET1054710.07
09:55 ET40010.02
10:00 ET29019.9
10:06 ET23469.815
10:08 ET2469.805
10:11 ET5879.8599
10:13 ET6009.88
10:15 ET266239.685
10:18 ET76139.655
10:20 ET20119.66
10:22 ET114009.675
10:24 ET7039.7101
10:27 ET24009.81
10:29 ET739289.89
10:33 ET1009.82
10:36 ET2009.81
10:38 ET5009.78
10:40 ET31289.765
10:42 ET11009.77
10:44 ET23009.725
10:45 ET8009.725
10:47 ET12079.77
10:49 ET8009.74
10:51 ET12309.7694
10:54 ET5009.72
10:56 ET4009.8
11:00 ET6569.815
11:03 ET1009.815
11:05 ET3009.85
11:07 ET39009.801
11:09 ET2009.8
11:12 ET4009.81
11:14 ET9009.83
11:16 ET165059.82
11:23 ET17009.81
11:25 ET4009.85
11:27 ET3009.8349
11:32 ET8109.75
11:34 ET4009.78
11:38 ET33179.76
11:43 ET1009.74
11:45 ET2009.74
11:48 ET1009.74
11:50 ET11909.7118
11:52 ET14029.8
11:54 ET15109.77
11:56 ET2359.7858
11:59 ET43959.74
12:01 ET3009.72
12:03 ET24069.7199
12:06 ET11269.76
12:08 ET9009.79
12:10 ET14009.82
12:15 ET1009.825
12:17 ET37709.85
12:21 ET26009.8
12:26 ET3999.82
12:28 ET1009.78
12:32 ET1009.75
12:33 ET2509.73
12:35 ET11009.76
12:37 ET5179.77
12:39 ET1009.73
12:42 ET26949.74
12:44 ET5009.7899
12:46 ET1009.78
12:48 ET8009.78
12:50 ET2849.77
12:53 ET25009.76
12:55 ET8159.79
12:57 ET1009.78
01:00 ET1809.7849
01:04 ET7009.75
01:06 ET30009.74
01:08 ET8009.735
01:09 ET19009.78
01:13 ET2009.8
01:15 ET6009.81
01:22 ET13099.81
01:27 ET7279.795
01:31 ET3009.78
01:33 ET9009.79
01:36 ET2009.791
01:38 ET11009.8
01:40 ET3009.81
01:44 ET5009.805
01:45 ET419639.9
01:47 ET370059.9101
01:54 ET8999.94
01:56 ET1009.94
02:00 ET6009.94
02:02 ET15669.95
02:03 ET10009.9201
02:05 ET3009.94
02:07 ET5009.87
02:09 ET12009.83
02:12 ET6009.85
02:14 ET9749.83
02:16 ET10009.77
02:18 ET9009.8
02:20 ET4009.82
02:21 ET1009.79
02:25 ET11519.84
02:32 ET14089.87
02:34 ET3009.87
02:36 ET9259.91
02:38 ET5009.895
02:39 ET4009.91
02:41 ET15009.89
02:45 ET12009.86
02:48 ET108009.78
02:50 ET20029.84
02:54 ET2009.845
02:56 ET2509.835
02:57 ET23639.88
03:01 ET15019.87
03:03 ET8169.76
03:06 ET1009.77
03:08 ET30009.77
03:10 ET5009.755
03:12 ET9009.75
03:14 ET1999.77
03:17 ET3009.74
03:19 ET2009.72
03:21 ET2959.75
03:24 ET1569.76
03:26 ET9989.77
03:28 ET8009.74
03:30 ET66119.685
03:32 ET27619.63
03:33 ET79249.62
03:35 ET26939.6
03:37 ET4009.6
03:39 ET27609.62
03:42 ET30429.63
03:44 ET37509.67
03:46 ET63739.625
03:48 ET1009.625
03:50 ET53029.7
03:51 ET36139.69
03:53 ET75569.77
03:55 ET58019.805
03:57 ET81809.79
04:00 ET493119.72
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCVM
CEL-SCI Corp
426.8M
-11.3x
---
United StatesALDX
Aldeyra Therapeutics Inc
425.8M
-6.7x
---
United StatesHOWL
Werewolf Therapeutics Inc
428.3M
0.0x
---
United StatesADAG
Adagene Inc
433.6M
0.0x
---
United StatesMIRM
Mirum Pharmaceuticals Inc
432.0M
-2.4x
---
United StatesPSTX
Poseida Therapeutics Inc
434.4M
-2.8x
---
As of 2021-12-08

Company Information

CEL-SCI Corp is a clinical-stage biotechnology company. The Company is focused on activating the immune system to fight cancer and infectious diseases. The Company is engaged in research and developing the treatments for the cancer and other diseases by using the immune system. The Company’s lead investigational therapy Multikine (Leukocyte Interleukin, Injection) is in a pivotal Phase 3 clinical trial. Its Multikine is an investigational immunotherapy under development for the potential treatment of certain head and neck cancers. The Company using its Ligand Epitope Antigen Presentation System (LEAPS) technology platform is investigating product candidates include CEL-2000 and CEL-4000. CEL-2000 and CEL-4000, vaccine product candidates under development for treatment of rheumatoid arthritis. It is also investigating LEAPS COVID-19 conjugates as a potential treatment of coronavirus (COVID-19) in hospitalized and at-high-risk patients at the University of Georgia’s (UGA) Center.

Contact Information

Headquarters
8229 Boone Blvd Ste 802VIENNA, VA, United States 22182-2634
Phone
703-506-9460
Fax
703-506-9471

Executives

Chief Executive Officer, Treasurer, Director
Geert Kersten
Senior Vice President - Operations, Corporate Secretary
Patricia Prichep
Senior Vice President - Regulatory Affairs
John Cipriano
Senior Vice President - Research, Cellular Immunology
Daniel Zimmerman
Chief Scientific Officer
Eyal Talor

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$426.8M
Revenue (TTM)
$28.6K
Shares Outstanding
43.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.17
EPS
$-0.86
Book Value
$0.51
P/E Ratio
-11.3x
Price/Sales (TTM)
14,945.4
Price/Cash Flow (TTM)
---
Operating Margin
-127,219.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.